Eukaryotic initiation factor 6 repression mitigates atherosclerosis progression by inhibiting macrophages expressing Fasn

AbstractAtherosclerosis, a chronic inflammatory disease that often leads to myocardial infarction and stroke, is mainly caused by lipid accumulation. Eukaryotic initiation factor 6 (Eif6) is a rate-limiting factor in protein translation of transcription factors necessary for lipogenesis. To determine whetherEif6 affects atherosclerosis,Eif6+/ − mice were crossed intoApoe −/− background.Apoe −/−/Eif6+/− mice on high fat diet showed significant reduction in atherosclerotic lesions and necrotic core content in aortic root sections in comparison withApoe −/− mice. RNA-Seq was used to investigate the effect of Eif6 in aorta. Deficiency of Eif6 shows broad effect on cell metabolism. Expression of genes for fatty acid synthesis including Fatty acid synthase (Fasn),Elovl3,Elovl6 andAcaca are down-regulated in aortas. Importantly, Fasn is decreased in macrophages. Results suggest that Eif6 deficiency may decrease atherosclerosis through inhibition of Fasn and lipids metabolism in macrophages.

Source: IUBMB Life - December 6, 2022 Category: Research Authors: Yang Chen, Zhenzhen Wang, Xuemei Xian, Yun Zhuang, Jiajia Chang, Xiaoqiang Zhan, Xufeng Han, Quangang Chen, Zhangping Yang, Renjin Chen Tags: RESEARCH ARTICLE Source Type: research